AI in the Lab: Why Life Sciences Is Stuck in the Pilot Phase

LONDON – June 18, 2026 – In the high-stakes world of life sciences, the promise of artificial intelligence has been a siren song, luring researchers with visions of accelerated drug discovery and automated breakthroughs. Yet, for all the excitement, a new report reveals a stark reality: the AI revolution in the lab is largely stuck in first gear.

A second annual survey of over 110 life science professionals by Cenevo, a lab technology specialist, paints a picture of a sector caught in an AI paradox. While more than 60 percent of laboratories are actively exploring or piloting AI tools, the leap to full-scale production remains a chasm few have crossed. The most advanced form of this technology—AI agents capable of autonomously conducting complex workflows—is in production use in a mere 5 percent of labs. The industry is standing at the edge of a transformation, but seems unable to take the final, crucial step. The reason isn't a lack of ambition, but a far more fundamental and frustrating problem: the lab itself isn't ready.

The Data Dilemma: A Disconnected Reality

The primary bottleneck holding back AI's potential is not the technology itself, but the fragmented digital infrastructure of the modern laboratory. The Cenevo survey found that a staggering 55 percent of lab leaders cite a lack of integration between systems as their biggest data management problem. This is the digital equivalent of trying to assemble a puzzle with pieces from a dozen different boxes.

For decades, labs have accumulated a patchwork of specialized instruments, electronic lab notebooks (ELNs), and laboratory information management systems (LIMS), often from different vendors and built on incompatible platforms. The result is a landscape of data silos, where crucial information is trapped, inconsistent, or spread across disparate teams and machines. More than one-third of labs still rely on manual operations for key processes, a figure that, while an improvement over last year's 50 percent, highlights the persistent challenge of digitization.

This lack of connectivity neuters AI. Advanced algorithms thrive on vast, clean, and interconnected datasets. When data is messy, unstructured, or inaccessible, AI models cannot be trained effectively or trusted to produce reliable results. It's no surprise, then, that 42 percent of respondents still see data quality, overload, and management as significant barriers to AI adoption. "Concerns over fragmented data, as well as security and regulatory compliance, are hindering adoption," noted Cenevo CEO Keith Hale in the report. The industry seems to be waking up to the fact that you can't build a smart lab on a dumb foundation.

Shifting Budgets and Cautious Optimism

In response to this foundational weakness, a significant shift in spending is underway. Lab leaders are turning their backs on shiny, standalone AI tools that can't talk to the rest of their systems. Instead, investment priorities are now squarely focused on the unglamorous but essential work of building a connected ecosystem: automation, AI-enabled software that integrates, systems integration, and data infrastructure. For small and medium-sized organizations, connecting LIMS, ELNs, and instruments is a top priority for 62 percent of respondents.

This pragmatic pivot is coupled with a healthy dose of caution. The survey revealed that 58 percent of researchers harbor privacy or security concerns about current AI technologies. In a highly regulated field where intellectual property is paramount and patient data is sacrosanct, a "move fast and break things" approach is a non-starter. This isn't just about preventing data breaches; it's about ensuring the integrity and auditability of the entire research and development pipeline. The "black box" nature of some AI models is a source of anxiety, leading to a demand for AI tools built specifically for the scientific context—tools that are transparent, verifiable, and compliant.

This cautious optimism is perhaps the most realistic path forward. The industry isn't rejecting AI; it's recognizing that to harness it responsibly, it must first get its own house in order. The focus has moved from the "what" of AI to the "how" of its implementation.

From Hype to Workflow: Where AI Is Gaining Ground

Despite the integration hurdles, AI is not just a hypothetical. In specific, targeted applications, it is already delivering value. The survey shows that a quarter of labs are already using generative AI in full production, likely for tasks like generating novel molecular structures or optimizing experimental protocols.

The most common and mature application, however, is data analysis and interpretation, where 57 percent of labs are putting AI to work. In fields like genomics and proteomics, which generate datasets of a scale and complexity far beyond human cognitive capacity, AI is becoming an indispensable tool for identifying patterns, predicting outcomes, and surfacing novel insights from the noise.

This is the ground-level reality of AI adoption, far from the sci-fi vision of fully autonomous labs. The focus is on augmenting, not replacing, the scientist. Companies are developing AI assistants, like Cenevo's own Labguru Assistant, that function within existing workflows, offering real-time troubleshooting, protocol optimization, and data analysis using natural language. These tools are designed to operate within the lab's secure, compliant environment, providing auditable, traceable support that respects data sovereignty—directly addressing the security concerns that keep researchers up at night. The most successful implementations are those that solve a specific, nagging problem, like converting old paper-based protocols into structured digital workflows or enabling scientists to create automation scripts without needing to code.

Paving the Path to the Agentic Lab

The ultimate goal for many technology providers is the "agentic lab"—a fully connected, automated, and AI-driven environment where intelligent agents manage everything from inventory to complex experimental workflows. This vision, however, depends entirely on solving the connectivity problem first.

The survey data suggests that the industry understands this. The deliberate, infrastructure-first investment strategy is the necessary groundwork for the agentic future. Companies that can provide a unified platform—one that seamlessly integrates LIMS, ELNs, instruments, and data analytics—are the ones positioned to win. They are selling not just a piece of software, but a blueprint for the lab of the future.

As Keith Hale put it, labs are "prioritizing connectivity, automation, orchestration, and data management to ensure they can fully benefit from what AI can deliver." The journey toward a truly AI-enabled laboratory is not a sprint to buy the latest algorithm, but a methodical campaign to tear down digital walls and build a unified data ecosystem. The enthusiasm for AI is real, but the industry is learning that before it can run, it must first learn to connect the dots.